Last Updated：2025/11/28
In a recent clinical trial, researchers administered ebselen to patients to evaluate whether it could limit tissue damage after reperfusion.
See correct answer
In a recent clinical trial, researchers administered ebselen to patients to evaluate whether it could limit tissue damage after reperfusion.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
